Osterweis Capital Management Inc Iovance Biotherapeutics, Inc. Transaction History

Osterweis Capital Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $2.36 Million - $4.78 Million	-144,461 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$28.67 - $52.59 $185,781 - $340,783	6,480 Added 4.7%	144,461 $4.57 Million
Q4 2020 Feb 12, 2021	SELL	$28.04 - $50.26 $554,350 - $993,640	-19,770 Reduced 12.53%	137,981 $6.4 Million
Q3 2020 Nov 13, 2020	BUY	$27.75 - $36.3 $648,240 - $847,967	23,360 Added 17.38%	157,751 $5.19 Million
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $434,543 - $654,770	15,970 Added 13.49%	134,391 $3.69 Million
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $388,924 - $773,270	-19,904 Reduced 14.39%	118,421 $3.55 Million
Q4 2019 Feb 14, 2020	SELL	$17.95 - $29.41 $216,925 - $355,419	-12,085 Reduced 8.03%	138,325 $3.83 Million
Q3 2019 Nov 14, 2019	BUY	$17.99 - $26.0 $90,489 - $130,780	5,030 Added 3.46%	150,410 $2.74 Million
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $2.38 Million - $5.97 Million	-243,615 Reduced 62.63%	145,380 $3.57 Million
Q1 2019 May 15, 2019	BUY	$8.41 - $11.26 $3.27 Million - $4.38 Million	388,995 New	388,995 $3.7 Million
Q4 2018 Feb 14, 2019	SELL	$7.51 - $11.93 $3.41 Million - $5.42 Million	-454,295 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$11.25 - $17.7 $5.11 Million - $8.04 Million	454,295 New	454,295 $5.11 Million

320

238M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Osterweis Capital Management Inc with notifications on news.